FDA Inspection 1314570 — Baylor, Scott, And White, ART Program
The FDA completed an inspection of Baylor, Scott, And White, ART Program on Apr 14, 2026 in Temple, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 14, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Temple, TX (United States)